Insider Transactions Reported by 13 Insiders of ImmunityBio, Inc.

Symbol
IBRX on Nasdaq
Location
San Diego, CA

Insiders trading volume in the past year

ImmunityBio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Patrick Soon-Shiong Founder, Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner $499,522,215 22 Feb 2026
Barry J. Simon Director $16,909,279 -$1,783,602 -9.5% 24 Feb 2026
Richard Adcock CEO & President, Director $5,917,675 22 Feb 2026
David C. Sachs Chief Financial Officer $2,889,293 22 Feb 2026
John C. Thomas Former Director $1,086,143 31 Dec 2021
Regan J. Lauer Chief Accounting Officer $1,035,917 22 Feb 2026
Christobel Selecky Director $0 -$500,000 -100% 23 Feb 2026
Linda Maxwell Director 18 Jun 2025
Cheryl Cohen Director 18 Jun 2025
Bruce Wendel Director 12 Dec 2025
Michael D. Blaszyk Director 18 Jun 2025
John Owen Brennan Director 11 Jun 2024
Wesley Clark Director 18 Jun 2025

Recent Insider Transactions by Companies or Individuals for ImmunityBio, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Barry J. Simon IBRX Common Stock Sale -2.56% -75,000 2,850,821 24 Feb 2026 Direct
Christobel Selecky IBRX Common Stock Sale -100% $250,000 $10.00 -25,000 0 23 Feb 2026 Direct
Christobel Selecky IBRX Common Stock Options Exercise 25,000 25,000 23 Feb 2026 Direct
Christobel Selecky IBRX Stock Option (right to buy) Options Exercise -26.9% -25,000 67,937 23 Feb 2026 Direct
Barry J. Simon IBRX Common Stock Sale -5.34% $1,691,102 $10.25 -165,000 2,925,821 23 Feb 2026 Direct
David C. Sachs IBRX Common Stock Tax liability -6.45% -20,682 300,143 22 Feb 2026 Direct
David C. Sachs IBRX Common Stock Options Exercise 14.5% 40,650 320,825 22 Feb 2026 Direct
David C. Sachs IBRX Restricted Stock Units Options Exercise -50% -40,650 40,651 22 Feb 2026 Direct
Patrick Soon-Shiong IBRX Common Stock Tax liability -0.2% -58,170 29,757,911 22 Feb 2026 Direct
Patrick Soon-Shiong IBRX Common Stock Options Exercise 0.38% 114,329 29,816,081 22 Feb 2026 Direct
Patrick Soon-Shiong IBRX Restricted Stock Units Options Exercise -50% -114,329 114,329 22 Feb 2026 Direct
Regan J. Lauer IBRX Common Stock Tax liability -1.42% -1,673 115,875 22 Feb 2026 Direct
Regan J. Lauer IBRX Common Stock Options Exercise 3.58% 4,065 117,548 22 Feb 2026 Direct
Regan J. Lauer IBRX Restricted Stock Units Options Exercise -50% -4,065 4,065 22 Feb 2026 Direct
Richard Adcock IBRX Common Stock Tax liability -12.2% -77,560 560,344 22 Feb 2026 Direct
Richard Adcock IBRX Common Stock Options Exercise 31.4% 152,439 637,904 22 Feb 2026 Direct
Richard Adcock IBRX Restricted Stock Units Options Exercise -50% -152,439 152,439 22 Feb 2026 Direct
Barry J. Simon IBRX Common Stock Tax liability -0.19% -6,026 3,090,821 22 Feb 2026 Direct
Barry J. Simon IBRX Common Stock Options Exercise 0.49% 15,243 3,096,847 22 Feb 2026 Direct
Barry J. Simon IBRX Restricted Stock Units Options Exercise -50% -15,243 15,245 22 Feb 2026 Direct
Barry J. Simon IBRX Common Stock Sale -0.32% $92,500 $9.25 -10,000 3,081,604 20 Feb 2026 Direct
Patrick Soon-Shiong IBRX Common Stock Tax liability -0.4% -118,560 29,701,752 10 Feb 2026 Direct
Patrick Soon-Shiong IBRX Common Stock Options Exercise 0.93% 274,122 29,820,312 10 Feb 2026 Direct
Patrick Soon-Shiong IBRX Restricted Stock Units Options Exercise -33.3% -274,122 548,246 10 Feb 2026 Direct
David C. Sachs IBRX Common Stock Tax liability -13.2% -42,643 280,175 10 Feb 2026 Direct
David C. Sachs IBRX Common Stock Options Exercise 34.2% 82,236 322,818 10 Feb 2026 Direct
David C. Sachs IBRX Restricted Stock Units Options Exercise -33.3% -82,236 164,474 10 Feb 2026 Direct
Regan J. Lauer IBRX Common Stock Tax liability -1.95% -2,257 113,483 10 Feb 2026 Direct
Regan J. Lauer IBRX Common Stock Options Exercise 4.97% 5,482 115,740 10 Feb 2026 Direct
Regan J. Lauer IBRX Restricted Stock Units Options Exercise -33.3% -5,482 10,965 10 Feb 2026 Direct
Richard Adcock IBRX Common Stock Tax liability -22.4% -140,048 485,465 10 Feb 2026 Direct
Richard Adcock IBRX Common Stock Options Exercise 78% 274,122 625,513 10 Feb 2026 Direct
Richard Adcock IBRX Restricted Stock Units Options Exercise -33.3% -274,122 548,246 10 Feb 2026 Direct
Barry J. Simon IBRX Common Stock Sale -4.69% -151,967 3,091,604 20 Jan 2026 Direct
Christobel Selecky IBRX Common Stock Sale -100% -25,000 0 20 Jan 2026 Direct
Christobel Selecky IBRX Common Stock Options Exercise 25,000 25,000 20 Jan 2026 Direct
Christobel Selecky IBRX Stock Option (right to buy) Options Exercise -21.2% -25,000 92,937 20 Jan 2026 Direct
Christobel Selecky IBRX Common Stock Sale -100% $250,000 $5.00 -50,000 0 16 Jan 2026 Direct
Christobel Selecky IBRX Common Stock Options Exercise 50,000 50,000 16 Jan 2026 Direct
Christobel Selecky IBRX Stock Option (right to buy) Options Exercise -29.8% -50,000 117,937 16 Jan 2026 Direct
David C. Sachs IBRX Common Stock Tax liability -6.03% -15,435 240,582 31 Dec 2025 Direct
David C. Sachs IBRX Common Stock Options Exercise 13.5% 30,397 256,017 31 Dec 2025 Direct
David C. Sachs IBRX Restricted Stock Units Options Exercise -40% -30,397 45,602 31 Dec 2025 Direct
Richard Adcock IBRX Common Stock Tax liability -4.75% -17,510 351,391 31 Dec 2025 Direct
Richard Adcock IBRX Common Stock Options Exercise 10.3% 34,483 368,901 31 Dec 2025 Direct
Richard Adcock IBRX Restricted Stock Units Options Exercise -40% -34,483 51,731 31 Dec 2025 Direct
Bruce Wendel IBRX Stock Option (right to buy) Award 146,020 146,020 12 Dec 2025 Direct
Christobel Selecky IBRX Stock Option (right to buy) Award 162,786 162,786 18 Jun 2025 Direct
Cheryl Cohen IBRX Stock Option (right to buy) Award 162,786 162,786 18 Jun 2025 Direct
Michael D. Blaszyk IBRX Stock Option (right to buy) Award 162,786 162,786 18 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.